Business Context and Reporting Period
This Form 8-K is filed by Oculus Innovative Sciences, Inc. (not Sonoma Pharmaceuticals, Inc.) on August 7, 2014. The report announces the issuance of a press release detailing financial results for the fiscal quarter ended June 30, 2014.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are contained within the press release furnished as Exhibit 99.1, which is incorporated by reference but not reproduced in the body of this 8-K.
Material Changes
The filing does not explicitly list material changes versus the prior comparable period. It serves solely as a notification that the Q2 2014 results have been released to the public.
Guidance, Outlook, and Risks
- Forward-Looking Statements: The report contains forward-looking statements regarding intentions, beliefs, expectations, and strategies.
- Risks and Uncertainties: Management notes that actual outcomes may differ materially from forecasts due to risks discussed in the Company's Annual Report on Form 10-K and other SEC filings.
- Disclaimer: The Company does not undertake an obligation to update forward-looking statements to reflect events occurring after the date of this report, except as required by law.
Investor Verification Checklist
- Verify the specific financial figures (revenue, net income, cash position) by reviewing Exhibit 99.1 (the August 7, 2014 Press Release).
- Confirm the registrant name is Oculus Innovative Sciences, Inc. and not Sonoma Pharmaceuticals, Inc.
- Review the most recent Form 10-K for a detailed list of risk factors referenced in this filing.
- Check for any subsequent updates to the forward-looking statements provided in the press release.